Still's Disease (cont.)

Medical Editor:
Medical Editor:

Is it possible to prevent Still's disease?

There is no prevention for Still's disease.

What Still's disease research is being done?

A wide variety of research is ongoing related to Still's disease. While intravenous immunoglobulin therapy has been used in adult-onset Still's disease, more studies are needed to confirm these results.

Also, TNF-inhibitors (etanercept [Enbrel] and infliximab [Remicade]) have been used successfully in people who have failed other treatments (much as they are now used in rheumatoid arthritis). The intravenous infusions of infliximab helped decrease the Still's disease signs and symptoms, including fever, arthritis, muscle pains, enlarged spleen, and rash, in virtually all patients in some studies.

What is the outlook (prognosis) with Still's disease?

The fever and other systemic features tend to run their course within several months. The arthritis can be a long-term problem. It usually stays on after the systemic features have gone. The arthritis can then become chronic and persist into adulthood. Persisting arthritis of the wrists, with eventual fusion, is common. Newer biologic treatments are likely to be beneficial in stopping the progressive joint damage.

REFERENCES:

Klippel, J.H., et al. Primer on the Rheumatic Diseases. New York: Springer, 2008.

Koopman, William, et al., eds. Clinical Primer of Rheumatology. Philadelphia: Lippincott Williams & Wilkins, 2003.

Ruddy, Shaun, et al., eds. Kelley's Textbook of Rheumatology. Philadelphia: W.B. Saunders Co., 2000.


Medically Reviewed by a Doctor on 10/22/2013

Patient Comments

Viewers share their comments

Still's Disease - Treatment Question: What was the treatment for your still's disease?
Still's Disease - Symptoms Question: What symptoms did you experience with your Still's disease?

STAY INFORMED

Get the Latest health and medical information delivered direct to your inbox!